Cocaine Use Disorder
Cocaine Use Disorder (CUD) is characterized as a substance use disorder in which biological, psychological, and genetic characteristics are supposed to predispose an individual to addiction. Cocaine causes the brain to release large amounts of a chemical called dopamine. This chemical activated the reward centre of the brain. Over time, more cocaine is needed to cause the same release of chemicals, leading to misuse.
Currently, no drug is approved to treat cocaine addiction; however, psychosocial treatment is the standard treatment for addicted patients. The social stigma revolving around Cocaine Use Disorder and lack of awareness about the misuse obstructs the creation of standard CUD treatment options.
Explore more about the Cocaine Use Disorder condition, its causes, signs and symptoms, epidemiological insights and currently available therapeutic options through DelveInsight’s Newsletter. It also includes the recent news in the Cocaine Use Disorder market, its pipeline therapies, ongoing clinical trials, key pharmaceutical companies working in the CUD domain. Gain rich insights into significant collaborations, licensing opportunities, and conferences that are taking place in the Cocaine Use Disorder field.
Are you curious about what the coming years hold for the Cocaine Use Disorder market and how pharma companies are working to push the drug development? Download our Newsletter by simply filling up the form towards the right.
Subscribe to our mailing list and stay informed about all the fresh updates in the Substance Use Disorder market.
Know more about What's covered:
- Indication overview
- Signs, symptoms, and diagnosis
- Epidemiological trends
- Treatment approaches
- R&D in the field
- Top conferences
- News flash
- Recent Research Activities
- Support from International organizations
- Market insights
- Cocaine Use Disorder Market Dynamics
- Collaborations and deals in the domain